Treatment with vascular endothelial growth factor-A worsens cognitive recovery in a rat model of mild traumatic brain injury
Mild traumatic brain injury (mTBI) is a common and unmet clinical issue, with limited treatments available to improve recovery. The cerebrovascular system is vital to provide oxygen and nutrition to the brain, and a growing body of research indicates that cerebrovascular injury contributes to mTBI s...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2022-10-01
|
| Series: | Frontiers in Molecular Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2022.937350/full |
| _version_ | 1798027449665060864 |
|---|---|
| author | Mujun Sun Tamara L. Baker Campbell T. Wilson Rhys D. Brady Richelle Mychasiuk Glenn R. Yamakawa Anh Vo Trevor Wilson Stuart J. McDonald Sandy R. Shultz Sandy R. Shultz Sandy R. Shultz |
| author_facet | Mujun Sun Tamara L. Baker Campbell T. Wilson Rhys D. Brady Richelle Mychasiuk Glenn R. Yamakawa Anh Vo Trevor Wilson Stuart J. McDonald Sandy R. Shultz Sandy R. Shultz Sandy R. Shultz |
| author_sort | Mujun Sun |
| collection | DOAJ |
| description | Mild traumatic brain injury (mTBI) is a common and unmet clinical issue, with limited treatments available to improve recovery. The cerebrovascular system is vital to provide oxygen and nutrition to the brain, and a growing body of research indicates that cerebrovascular injury contributes to mTBI symptomatology. Vascular endothelial growth factor-A (VEGF-A) is a potent promoter of angiogenesis and an important modulator of vascular health. While indirect evidence suggests that increased bioavailability of VEGF-A may be beneficial after mTBI, the direct therapeutic effects of VEGF-A in this context remains unknown. This study therefore aimed to determine whether intracerebroventricular administration of recombinant VEGF-A could improve recovery from mTBI in a rat model. Male and female Sprague–Dawley rats were assigned to four groups: sham + vehicle (VEH), sham + VEGF-A, mTBI + VEH, mTBI + VEGF-A. The mTBI was induced using the lateral impact model, and treatment began at the time of the injury and continued until the end of the study. Rats underwent behavioral testing between days 1 and 10 post-injury, and were euthanized on day 11 for post-mortem analysis. In males, the mTBI + VEGF-A group had significantly worse cognitive recovery in the water maze than all other groups. In females, the VEGF treatment worsened cognitive performance in the water maze regardless of mTBI or sham injury. Analysis of hippocampal tissue found that these cognitive deficits occurred in the presence of gene expression changes related to neuroinflammation and hypoxia in both male and female rats. These findings indicate that the VEGF-A treatment paradigm tested in this study failed to improve mTBI outcomes in either male or female rats. |
| first_indexed | 2024-04-11T18:51:36Z |
| format | Article |
| id | doaj.art-3e3e388f4c444415ad79dd79c2645b6c |
| institution | Directory Open Access Journal |
| issn | 1662-5099 |
| language | English |
| last_indexed | 2024-04-11T18:51:36Z |
| publishDate | 2022-10-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Molecular Neuroscience |
| spelling | doaj.art-3e3e388f4c444415ad79dd79c2645b6c2022-12-22T04:08:19ZengFrontiers Media S.A.Frontiers in Molecular Neuroscience1662-50992022-10-011510.3389/fnmol.2022.937350937350Treatment with vascular endothelial growth factor-A worsens cognitive recovery in a rat model of mild traumatic brain injuryMujun Sun0Tamara L. Baker1Campbell T. Wilson2Rhys D. Brady3Richelle Mychasiuk4Glenn R. Yamakawa5Anh Vo6Trevor Wilson7Stuart J. McDonald8Sandy R. Shultz9Sandy R. Shultz10Sandy R. Shultz11Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, AustraliaDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, AustraliaDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, AustraliaDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, AustraliaDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, AustraliaDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, AustraliaMonash Health Translation Precinct, Monash University, Melbourne, VIC, AustraliaMonash Health Translation Precinct, Monash University, Melbourne, VIC, AustraliaDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, AustraliaDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, AustraliaDepartment of Medicine, The University of Melbourne, Parkville, VIC, AustraliaHealth and Human Services, Vancouver Island University, Nanaimo, BC, CanadaMild traumatic brain injury (mTBI) is a common and unmet clinical issue, with limited treatments available to improve recovery. The cerebrovascular system is vital to provide oxygen and nutrition to the brain, and a growing body of research indicates that cerebrovascular injury contributes to mTBI symptomatology. Vascular endothelial growth factor-A (VEGF-A) is a potent promoter of angiogenesis and an important modulator of vascular health. While indirect evidence suggests that increased bioavailability of VEGF-A may be beneficial after mTBI, the direct therapeutic effects of VEGF-A in this context remains unknown. This study therefore aimed to determine whether intracerebroventricular administration of recombinant VEGF-A could improve recovery from mTBI in a rat model. Male and female Sprague–Dawley rats were assigned to four groups: sham + vehicle (VEH), sham + VEGF-A, mTBI + VEH, mTBI + VEGF-A. The mTBI was induced using the lateral impact model, and treatment began at the time of the injury and continued until the end of the study. Rats underwent behavioral testing between days 1 and 10 post-injury, and were euthanized on day 11 for post-mortem analysis. In males, the mTBI + VEGF-A group had significantly worse cognitive recovery in the water maze than all other groups. In females, the VEGF treatment worsened cognitive performance in the water maze regardless of mTBI or sham injury. Analysis of hippocampal tissue found that these cognitive deficits occurred in the presence of gene expression changes related to neuroinflammation and hypoxia in both male and female rats. These findings indicate that the VEGF-A treatment paradigm tested in this study failed to improve mTBI outcomes in either male or female rats.https://www.frontiersin.org/articles/10.3389/fnmol.2022.937350/fullconcussioncerebrovascularVEGF-Aintracerebroventricular administrationneuroinflammationhypoxia |
| spellingShingle | Mujun Sun Tamara L. Baker Campbell T. Wilson Rhys D. Brady Richelle Mychasiuk Glenn R. Yamakawa Anh Vo Trevor Wilson Stuart J. McDonald Sandy R. Shultz Sandy R. Shultz Sandy R. Shultz Treatment with vascular endothelial growth factor-A worsens cognitive recovery in a rat model of mild traumatic brain injury Frontiers in Molecular Neuroscience concussion cerebrovascular VEGF-A intracerebroventricular administration neuroinflammation hypoxia |
| title | Treatment with vascular endothelial growth factor-A worsens cognitive recovery in a rat model of mild traumatic brain injury |
| title_full | Treatment with vascular endothelial growth factor-A worsens cognitive recovery in a rat model of mild traumatic brain injury |
| title_fullStr | Treatment with vascular endothelial growth factor-A worsens cognitive recovery in a rat model of mild traumatic brain injury |
| title_full_unstemmed | Treatment with vascular endothelial growth factor-A worsens cognitive recovery in a rat model of mild traumatic brain injury |
| title_short | Treatment with vascular endothelial growth factor-A worsens cognitive recovery in a rat model of mild traumatic brain injury |
| title_sort | treatment with vascular endothelial growth factor a worsens cognitive recovery in a rat model of mild traumatic brain injury |
| topic | concussion cerebrovascular VEGF-A intracerebroventricular administration neuroinflammation hypoxia |
| url | https://www.frontiersin.org/articles/10.3389/fnmol.2022.937350/full |
| work_keys_str_mv | AT mujunsun treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT tamaralbaker treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT campbelltwilson treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT rhysdbrady treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT richellemychasiuk treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT glennryamakawa treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT anhvo treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT trevorwilson treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT stuartjmcdonald treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT sandyrshultz treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT sandyrshultz treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury AT sandyrshultz treatmentwithvascularendothelialgrowthfactoraworsenscognitiverecoveryinaratmodelofmildtraumaticbraininjury |